Literature DB >> 10593593

Attenuation of ozone-induced lung injury by interleukin-10.

P G Reinhart1, S K Gupta, D K Bhalla.   

Abstract

Ozone (O3), an oxidant air pollutant, is capable of producing pulmonary inflammation and injury. Exposure to O3 results in the release of inflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) by alveolar macrophages. In addition, O3 exposure results in an increased expression of the inducible isoform of nitric oxide synthetase (iNOS). Interleukin-10 (IL-10) is an anti-inflammatory cytokine which inhibits the synthesis of TNF-alpha and IL-1 by macrophages and decreases the expression of iNOS. To test the protective properties of IL-10 in vivo, on the pulmonary injury induced by O3 exposure, we intratracheally instilled rat recombinant IL-10 1 h prior to O3 exposure (0.8 ppm x 3 h). Approximately 10-12 h following exposure, the animals were sacrificed and the bronchoalveolar lavage fluid (BALF) collected. The quantification of albumin, protein and fibronectin in the BALF provided a means of assessing pulmonary injury while the analysis of the BALF cells reflected the inflammatory response. Ozone exposure resulted in a significant (P<0.05) increase in BALF albumin, protein and fibronectin content as compared to air-exposed controls. In addition, significant increases in the percentage of BALF polymorphonuclear leukocytes (PMNs) and tissue expression of fibronectin mRNA were observed. The intratracheal instillation of IL-10 prior to O3 exposure resulted in a significant reduction in BALF albumin, protein and fibronectin content, and lung fibronectin mRNA as compared to O3 exposure alone. The data shows that IL-10, when given intratracheally, significantly reduces the pulmonary injury following O3 exposure in the rat. However, since the PMNs and the levels of albumin, protein and fibronectin in the IL-10 treated group did not reach baseline values, we conclude that other mediators of inflammation and injury not regulated by IL-10 also contribute to the pathophysiology of O3-induced lung injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10593593     DOI: 10.1016/s0378-4274(99)00136-8

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  7 in total

1.  Classical and alternative macrophage activation in the lung following ozone-induced oxidative stress.

Authors:  Vasanthi R Sunil; Kinal Patel-Vayas; Jianliang Shen; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2012-06-19       Impact factor: 4.219

2.  Regulation of ozone-induced lung inflammation and injury by the β-galactoside-binding lectin galectin-3.

Authors:  Vasanthi R Sunil; Mary Francis; Kinal N Vayas; Jessica A Cervelli; Hyejeong Choi; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2015-02-25       Impact factor: 4.219

3.  Ozone enema: a model of microscopic colitis in rats.

Authors:  R Eliakim; F Karmeli; D Rachmilewitz; P Cohen; A Zimran
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

Review 4.  Lung macrophages: current understanding of their roles in Ozone-induced lung diseases.

Authors:  Sonika Patial; Yogesh Saini
Journal:  Crit Rev Toxicol       Date:  2020-05-27       Impact factor: 5.635

5.  Carcinoembryonic antigen promotes tumor cell survival in liver through an IL-10-dependent pathway.

Authors:  J Milburn Jessup; R Samara; P Battle; L M Laguinge
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

6.  Protective role of interleukin-10 in ozone-induced pulmonary inflammation.

Authors:  Gillian S Backus; Reuben Howden; Jennifer Fostel; Alison K Bauer; Hye-Youn Cho; Jacqui Marzec; David B Peden; Steven R Kleeberger
Journal:  Environ Health Perspect       Date:  2010-09-08       Impact factor: 9.031

7.  Small Immunomodulatory Molecules as Potential Therapeutics in Experimental Murine Models of Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS).

Authors:  Dilip Shah; Pragnya Das; Suchismita Acharya; Beamon Agarwal; Dale J Christensen; Stella M Robertson; Vineet Bhandari
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.